Literature DB >> 32244985

Treatment Strategies and Survival Outcomes in Breast Cancer.

Kwok-Leung Cheung1.   

Abstract

Treatment strategies for breast cancer are wide-ranging and often based on a multi-modality approach, depending on the stage and biology of the tumour and the acceptance and tolerance of the patient [...].

Entities:  

Year:  2020        PMID： 32244985     DOI： 10.3390/cancers12030735

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN： 2072-6694            Impact factor:   6.639


  5 in total

Review 1.  Drug Delivery of Natural Products Through Nanocarriers for Effective Breast Cancer Therapy: A Comprehensive Review of Literature.

Authors:  Kah Min Yap; Mahendran Sekar; Shivkanya Fuloria; Yuan Seng Wu; Siew Hua Gan; Nur Najihah Izzati Mat Rani; Vetriselvan Subramaniyan; Chandrakant Kokare; Pei Teng Lum; M Yasmin Begum; Shankar Mani; Dhanalekshmi Unnikrishnan Meenakshi; Kathiresan V Sathasivam; Neeraj Kumar Fuloria
Journal:  Int J Nanomedicine       Date:  2021-12-02

2.  Treatment outcomes and its associated factors among breast cancer patients at Kitui Referral Hospital.

Authors:  Mwendwa Dickson Wambua; Amsalu Degu; Gobezie T Tegegne
Journal:  SAGE Open Med       Date:  2022-01-08

3.  CDKN1C as a prognostic biomarker correlated with immune infiltrates and therapeutic responses in breast cancer patients.

Authors:  Jianguo Lai; Xiaoyi Lin; Fangrong Cao; Hsiaopei Mok; Bo Chen; Ning Liao
Journal:  J Cell Mol Med       Date:  2021-08-31       Impact factor: 5.310

4.  Prognostic and immune infiltration signatures of proteasome 26S subunit, non-ATPase (PSMD) family genes in breast cancer patients.

Authors:  Do Thi Minh Xuan; Chung-Che Wu; Tzu-Jen Kao; Hoang Dang Khoa Ta; Gangga Anuraga; Vivin Andriani; Muhammad Athoillah; Chung-Chieh Chiao; Yung-Fu Wu; Kuen-Haur Lee; Chih-Yang Wang; Jian-Ying Chuang
Journal:  Aging (Albany NY)       Date:  2021-11-28       Impact factor: 5.682

5.  KIF18B promotes breast cancer cell proliferation, migration and invasion by targeting TRIP13 and activating the Wnt/β-catenin signaling pathway.

Authors:  Lan Liu; Zhaofeng Zhang; Xiulin Xia; Jing Lei
Journal:  Oncol Lett       Date:  2022-02-08       Impact factor: 2.967
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.